| Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial JH Christensen, P Gustenhoff, E Korup, J Aaroe, E Toft, T Moller, ... Bmj 312 (7032), 677-678, 1996 | 486 | 1996 |
| Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n− 3 fatty acids JH Christensen, MS Christensen, J Dyerberg, EB Schmidt The American journal of clinical nutrition 70 (3), 331-337, 1999 | 268 | 1999 |
| Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction JH Christensen, E Korup, J Aarøe, E Toft, J Møller, K Rasmussen, ... American Journal of Cardiology 79 (12), 1670-1673, 1997 | 246 | 1997 |
| Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography JH Christensen, HA Skou, L Fog, VE Hansen, T Vesterlund, J Dyerberg, ... Circulation 103 (5), 651-657, 2001 | 240 | 2001 |
| C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease T Madsen, HA Skou, VE Hansen, L Fog, JH Christensen, E Toft, ... The American journal of cardiology 88 (10), 1139-1142, 2001 | 221 | 2001 |
| N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial M Svensson, EB Schmidt, KA Jørgensen, JH Christensen, ... Clinical journal of the American Society of Nephrology 1 (4), 780-786, 2006 | 197 | 2006 |
| Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 … EB Schmidt, W Koenig, N Khuseyinova, JH Christensen Atherosclerosis 196 (1), 420-424, 2008 | 179 | 2008 |
| The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose–response study T Madsen, JH Christensen, M Blom, EB Schmidt British Journal of Nutrition 89 (4), 517-522, 2003 | 160 | 2003 |
| Effects of trans-and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study J Dyerberg, DC Eskesen, PW Andersen, A Astrup, B Buemann, ... European Journal of Clinical Nutrition 58 (7), 1062-1070, 2004 | 156 | 2004 |
| Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids M Svensson, JH Christensen, EB Schmidt, KA Jorgensen US Patent App. 11/979,539, 2008 | 147 | 2008 |
| The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma S Horwitz, OA O'connor, B Pro, L Trümper, S Iyer, R Advani, NL Bartlett, ... Annals of Oncology 33 (3), 288-298, 2022 | 140 | 2022 |
| Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids M Svensson, JH Christensen, EB Schmidt, KA Jorgensen US Patent App. 11/979,540, 2008 | 137 | 2008 |
| Heart rate variability and plasma lipids in men with and without ischaemic heart disease JH Christensen, E Toft, MS Christensen, EB Schmidt Atherosclerosis 145 (1), 181-186, 1999 | 132 | 1999 |
| N-3 fatty acids from fish and coronary artery disease: implications for public health EB Schmidt, HA Skou, JH Christensen, J Dyerberg Public Health Nutrition 3 (1), 91-98, 2000 | 129 | 2000 |
| n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. JH Christensen Danish Medical Bulletin 50 (4), 347-367, 2003 | 108 | 2003 |
| Omega-3 polyunsaturated fatty acids and heart rate variability JH Christensen Frontiers in physiology 2, 84, 2011 | 104 | 2011 |
| Heart rate variability and n‐3 polyunsaturated fatty acids in patients with diabetes mellitus JH Christensen, HA Skou, T Madsen, I Tørring, EB Schmidt Journal of internal medicine 249 (6), 545-552, 2001 | 95 | 2001 |
| The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF M Svensson, JH Christensen, J Sølling, EB Schmidt American journal of kidney diseases 44 (1), 77-83, 2004 | 92 | 2004 |
| The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study M Svensson, EB Schmidt, KA Jørgensen, JH Christensen Nephrology Dialysis Transplantation 23 (9), 2918-2924, 2008 | 83 | 2008 |
| A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients S Bhandari, PA Kalra, J Kothari, PM Ambühl, JH Christensen, AM Essaian, ... Nephrology Dialysis Transplantation 30 (9), 1577-1589, 2015 | 82 | 2015 |
